Inventor · disambiguated record
Lucienne V. Ronco
Also filed as: RONCO LUCIENNE V
4 granted patents·3 pending applications·8 citations·filing 2018–2022
68Inventor score
Files withFULCRUM THERAPEUTICS INC7
Top patents by PatentIndex Score
7 records- 0188US10342786B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·4 cites·19 claims
- 0286US10537560B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·4 cites·28 claims
- 0377US2023257743A1Use of p38 inhibitors to reduce expression of dux4FULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0475US2022282254A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0572US2022133704A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0670US11479770B2Use of p38 inhibitors to reduce expression of DUX4FULCRUM THERAPEUTICS INC·Filed 2018·Granted Oct 25, 2022·0 cites·8 claims
- 0767US11291659B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 5, 2022·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Lucienne V. Ronco files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →